期刊文献+

当归四逆汤联合针刺治疗糖尿病周围神经病变的临床观察 被引量:2

Clinical Observation of Using Angelica Sini Decoction Combined with Acupuncture Treatment on Diabetic Peripheral Neuropathy Patients
下载PDF
导出
摘要 目的:观察当归四逆汤联合针刺治疗糖尿病周围神经病变的临床疗效。方法:将60例糖尿病周围神经患者随机分成两组,治疗组30例采用当归四逆汤联合针刺治疗,对照组30例给予当归四逆汤治疗。分别于治疗前及治疗后分别进行临床症状积分。结果:治疗组总有效率86.67%明显高于对照组66.67%(P<0.05);治疗组治疗后肌电图、空腹血糖、糖化血红蛋白、血液流变分别为(48.6±4.2)m/s、(6.4±0.8)mmol/L、(6.4±0.8)%、(1.40±0.15)mpa,明显优于对照组(40.5±3.4)m/s、(7.5±1.6)mmol/L、(7.0±1.0)%、(1.51±0.13)mpa,差异具有统计学意义(P<0.05)。结论:当归四逆汤联合针刺治疗糖尿病周围神经病变具有良好的效果。 Objective: To observeclinical efficacy ofAngelica Sini decoction combined with acupuncture treatment on diabetic peripheral neuropathy patients. Methods: 60 patients with diabetic peripheral neuropathy were randomly divided into two groups : the treatment group, 30 patients were treated withAngelica Sini decoction combined with acupuncture, the control group, 30 patients were treated withAngelica Sini Decoction. Record the clinical symptom scores of 2 groups of patients respectively before and after treatment. Results: The total effective rate of treatment group (86.67%) was significantly higher than that of the control group (66.67%) (P<0.05), After treatment, the EMG, FBG, glycosylated hemoglobin, and blood rheological values of the treatment group wererespectively(48.6±4.2)m/s,(6.4±0.8)mmol/L,(6.4±0.8)%, and(1.40±0.15)mpa, which are significantly better than these of the control group(40.5±3.4)m/s,(7.5±1.6)mmol/L,(7.0±1.0)%, and(1.51±0.13)mpa. The difference was statistically significant (P<0.05).Conclusion: UsingAngelica Sini decoction combined with acupuncture treatment for diabetic peripheral neuropathy patients get good results.
作者 汪朝振 陈俊 张太阳 WANG Zhao-zhen;CHEN Jun;ZHANG Tai-yang(Nanchang Integrative Medicine Hospital of Endocrinology, Jiangxi Nanchang 330006, China)
出处 《药品评价》 CAS 2016年第24期48-49,56,共3页 Drug Evaluation
关键词 当归四逆汤 针刺 糖尿病周围神经病变 Angelica Sini Tang Acupuncture Diabetic Peripheral Neuropathy
  • 相关文献

参考文献2

二级参考文献19

  • 1Cameron NE,Eaton SE,Cotter MA,et al.Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.Diabetologia,2001,44:1973-1988.
  • 2Wada R,Nishizawa Y,Yagihashi N,et al.Effects of OPB-9195,anti-glycation agent,on experimental diabetic neuropathy.Eur J Clin Invest,2001,31:513-520.
  • 3Ziegler D.Therapy with antioxidants in human diabetic neuropathy.J Neurochem,2003,85(Suppl 2):15.
  • 4Takigawa T,Yasuda H,Terada M,et al.Increases in K+ conductance and Ca 2+influx under high glucose with suppressed Na+/K+-pump activity in rat myelinated nerve fibers.Neuroreport,2000,11:2547-2551.
  • 5Shimizu H,Ohtani KI,Tsuchiya T,et al.Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese type 2 diabetic (T2DM) patients.Diabetes Nutr Metab,2000,13:75-79.
  • 6Asano T,Saito Y,Kawakami M,et al.Fidarestat (SNK-860),a potent aldose reductase inhibitor,normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients.J Diabetes Complications,2002,16:133-138.
  • 7Cameron NE,Cotter MA.Vascular changes in animal models of diabetic neuropathy.J Neurochem,2003,85(Suppl 2):14.
  • 8Hounsom L,Corder R,Patel J,et al.Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy.Diabetologia,2001,44:424-428.
  • 9Purves T,Middlemas A,Agthong S,et al.A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy.FASEB J,2001,15:2508-2514.
  • 10Valls CJ,Povedano M,Montero J,et al.Diabetic polyneuropathy,axonal or demyelinating.Electromyogr Clin Neurophysiol,2002,42:3-6.

共引文献184

同被引文献17

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部